Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
9.11
-0.08 (-0.87%)
Nov 7, 2025, 4:00 PM EST - Market closed
Journey Medical Revenue
Journey Medical had revenue of $15.01M in the quarter ending June 30, 2025, with 1.04% growth. This brings the company's revenue in the last twelve months to $56.40M, down -27.40% year-over-year. In the year 2024, Journey Medical had annual revenue of $56.13M, down -29.11%.
Revenue (ttm)
$56.40M
Revenue Growth
-27.40%
P/S Ratio
3.55
Revenue / Employee
$1,375,537
Employees
41
Market Cap
239.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.13M | -23.05M | -29.11% |
| Dec 31, 2023 | 79.18M | 5.51M | 7.48% |
| Dec 31, 2022 | 73.67M | 10.54M | 16.69% |
| Dec 31, 2021 | 63.13M | 18.60M | 41.78% |
| Dec 31, 2020 | 44.53M | 9.61M | 27.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DERM News
- 3 days ago - Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 15 days ago - Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation to Participate in October 2025 Investor Conferences - GlobeNewsWire
- 2 months ago - Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon - Seeking Alpha
- 2 months ago - Journey Medical Corporation to Participate in September 2025 Investor Conferences - GlobeNewsWire
- 2 months ago - Journey Medical Corporation to Present at the Emerging Growth Conference - GlobeNewsWire
- 3 months ago - CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 3 months ago - Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript - Seeking Alpha